Bayer Secures FDA Approval for Lung Cancer Drug Hyrnuo
Bayer AG has received approval from the US Food and Drug Administration (FDA) for its new medication, Hyrnuo, targeted at treating a prevalent form of lung cancer. This approval is…
FDA Advances Key Treatments in Diabetes, Colitis, and Alzheimer’s
Healthcare providers received significant updates this week, with the US Food and Drug Administration (FDA) advancing multiple key treatments. These developments include a new application for insulin human (Afrezza) Inhalation…
FDA Urges Child-Resistant Packaging for Nicotine Pouches
The US Food and Drug Administration (FDA) has called on nicotine pouch manufacturers to implement child-resistant packaging in response to a concerning rise in accidental nicotine exposures among young children.…
Study Links Gut Immune Response to Peanut Immunotherapy Success
A new study has identified key factors that influence the effectiveness of peanut oral immunotherapy (OIT) in children, highlighting the role of gut immune responses. Conducted by a team led…